Walleye Capital
ANIP icon

Walleye Capital’s ANI Pharmaceuticals ANIP Stock Holding History

Walleye Capital’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.78M Sell
106,112
-76,963
-42% -$6.17M 0.03% 536
2026
Q1 		$14.1M Buy
183,075
+65,768
+56% +$5.13M 0.06% 286
2025
Q4 		$9.26M Sell
117,307
-99,000
-46% -$8.57M 0.03% 712
2025
Q3 		$19.8M Buy
216,307
+182,040
+531% +$14.8M 0.07% 254
2025
Q2 		$2.24M Buy
34,267
+2,983
+10% +$194K 0.01% 1425
2025
Q1 		$2.09M Sell
31,284
-40,725
-57% -$2.43M 0.01% 1383
2024
Q4 		$3.98M Buy
+72,009
New +$4.13M 0.01% 1241
2024
Q3 		– Sell
-10,849
Closed -$691K – 5230
2024
Q2 		$691K Buy
+10,849
New +$704K ﹤0.01% 3199
2023
Q4 		– Sell
-8,489
Closed -$493K – 4909
2023
Q3 		$493K Buy
+8,489
New +$490K ﹤0.01% 2837
2020
Q3 		– Sell
-9,235
Closed -$299K – 820
2020
Q2 		$299K Buy
+9,235
New +$331K 0.07% 335
2020
Q1 		– Sell
-239
Closed -$15K – 906
2019
Q4 		$15K Sell
239
-10,663
-98% -$706K ﹤0.01% 1623
2019
Q3 		$794K Buy
10,902
+7,246
+198% +$542K 0.05% 541
2019
Q2 		$301K Buy
3,656
+3,036
+490% +$216K 0.03% 733
2019
Q1 		$44K Buy
+620
New +$36.5K 0.01% 1235

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Walleye Capital's ANIP Position: Q2 2026 in Review

Walleye Capital reduced its ANI Pharmaceuticals (ANIP) stake by 42% in Q2 2026, selling an estimated $6.17M and leaving 106,112 shares worth $8.78M. The position accounts for 0.03% of the portfolio, ranked #536.

Walleye Capital first reported a position in ANIP in Q1 2019 and has held it in 14 quarters since. The position peaked at $19.8M in Q3 2025. 308 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • Walleye Capital held 106,112 shares of ANI Pharmaceuticals worth $8.78M as of Q2 2026.
  • Walleye Capital sold 76,963 ANI Pharmaceuticals shares in Q2 2026, an estimated $6.17M.
  • ANI Pharmaceuticals made up 0.03% of Walleye Capital's portfolio in Q2 2026, its #536 holding.
  • Walleye Capital first reported a position in ANI Pharmaceuticals in Q1 2019 and has held it in 14 quarters since.
  • Walleye Capital's ANI Pharmaceuticals position peaked at $19.8M in Q3 2025.
  • 308 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.